Trials / Completed
CompletedNCT03581071
Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety, pharmacokinetics, and pharmacodynamics in nondialysis (ND) and hemodialysis (HD) subjects with Chronic Kidney Disease (CKD) who receive a single administration of TS-143.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-143 |
Timeline
- Start date
- 2016-10-06
- Primary completion
- 2017-07-06
- Completion
- 2017-07-06
- First posted
- 2018-07-10
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03581071. Inclusion in this directory is not an endorsement.